- AI
- Arbitration
- Asia
- Automobile
- Bangladesh
- Banking
- Biodiversity
- Biological Inventions
- bLAWgathon
- Brand Valuation
- Business
- Celebrity Rights
- Company Act
- Company Law
- Competition Law
- Constitutional Law
- Consumer Law
- Consumer Protection Authority
- Copyright
- Copyright Infringement
- Copyright Litigation
- Corporate Law
- Counterfeiting
- Covid
- Design
- Digital Media
- Digital Right Management
- Dispute
- Educational Conferences/ Seminar
- Environment Law Practice
- ESIC Act
- EX-Parte
- Farmer Right
- Fashion Law
- FDI
- FERs
- Foreign filing license
- Foreign Law
- Gaming Industry
- GDPR
- Geographical Indication (GI)
- GIg Economy
- Hi Tech Patent Commercialisation
- Hi Tech Patent Litigation
- IBC
- India
- Indonesia
- Intellectual Property
- Intellectual Property Protection
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- IT Act
- IVF technique
- Judiciary
- Khadi Industries
- labour Law
- Legal Case
- Legal Issues
- Lex Causae
- Licensing
- Live-in relationships
- Lok Sabha Bill
- Marriage Act
- Maternity Benefit Act
- Media & Entertainment Law
- Mediation Act
- Member of Parliament
- Mergers & Acquisition
- Myanmar
- NCLT
- NEPAL
- News & Updates
- Non-Disclosure Agreement
- Online Gaming
- Patent Act
- Patent Commercialisation
- Patent Fess
- Patent Filing
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Marketing
- Patent Opposition
- Patent Rule Amendment
- Patents
- Personality rights
- pharma
- Pharma- biotech- Patent Commercialisation
- Pharma/Biotech Patent Litigations
- Pollution
- Posh Act
- Protection of SMEs
- RERA
- Section 3(D)
- Signapore
- Social Media
- Sports Law
- Stamp Duty
- Stock Exchange
- Surrogacy in India
- TAX
- Technology
- Telecom Law
- Telecommunications
- Thailand
- Trademark
- Trademark Infringement
- Trademark Litigation
- Trademark Registration in Foreign
- Traditional Knowledge
- UAE
- Uncategorized
- USPTO
- Vietnam
- WIPO
- Women Empower
A Change in Year Brings Change in IP Laws and Policy
The intellectual property (IP) concepts that are applied today to the national laws and international treaties and organizations date back to eighteenth century. The IP laws vary from one country to another. The changes in Intellectual property laws also depend on the changes in technology. Due to emerging new technologies and R&D activities, the intellectual … Continue reading A Change in Year Brings Change in IP Laws and Policy
Read more »Two-Days International Symposium on Strategies for Managing Pharmaceutical, Biotechnology & Chemical Patent Portfolios
We are happy to inform you all that IIPRD and Khurana & Khurana, in association with Cantor Colburn (US) and Fukami Patent Office (Japan) are holding an International Patent Symposium covering all major and relevant Pharmaceutical/Biotechnology Related Patent issues in the month of February, 2014 in India. The Two-Days International Symposium would be covering Strategies for Managing … Continue reading Two-Days International Symposium on Strategies for Managing Pharmaceutical, Biotechnology & Chemical Patent Portfolios
Read more »Microsoft’s Acquisition of Nokia
This is one of the most interesting and important news in technology sector. In case you missed it, the story is: Microsoft and Nokia announced on September 3 that Microsoft would be buying Nokia’s handset business and licensing various patents for about $7 billion. Many industry experts have already started debating about Microsoft’s acquisition of Nokia’s handset … Continue reading Microsoft’s Acquisition of Nokia
Read more »IIPRD assists Venus Remedies in Successful Technology Out-licensing of Potentox to Adcock, South Africa
Venus Remedies Ltd. has successfully out-licensed its new generation antibiotic drug Potentox to Adcock Ingram Ltd. in South Africa earlier this year. Potentox is a Fixed Dose Combination (FDC) of Cefepime Hydrochloride & Amikacin Sulphate developed by Venus Remedies Ltd., indicated for treatment of Nosocomial Pneumonia & Febrile Neutropenia and available as dry powder for … Continue reading IIPRD assists Venus Remedies in Successful Technology Out-licensing of Potentox to Adcock, South Africa
Read more »Three-Days International Symposium on Patent Portfolio Management Strategies for IP Groups & R&D Scientists, Patent Agents and Attorneys of Pharmaceutical, Biotech, Chemical & Drug Industries
We are happy to inform you all that IIPRD and Khurana & Khurana, in association with Sughrue Mion (US), Schoen & Partners (EP), and Marietti Gislon S.R.L are holding their annual International Patent Symposium covering all major and relevant Pharmaceutical/Biotechnology Related Patent issues in the month of September, 2013 in India. The Three-Days International Symposium … Continue reading Three-Days International Symposium on Patent Portfolio Management Strategies for IP Groups & R&D Scientists, Patent Agents and Attorneys of Pharmaceutical, Biotech, Chemical & Drug Industries
Read more »New Guidelines for Computer Implmented Inventions. Are we still clear on what is Statutory?
It was on 8’th August 2013 that the Patent Office, based on feedback from numerous stakeholders, came out with yet another draft of guidelines on subject matters that relate to Computer Implemented Inventions, interchangeably also referred to as Computer Related Inventions (CRI) hereinafter. The mandate of the instant article is not to assess or question … Continue reading New Guidelines for Computer Implmented Inventions. Are we still clear on what is Statutory?
Read more »Khurana & Khurana opens another Branch Office in Bangalore
Khurana & Khurana, Advocates and IP Attorneys (K&K) along with its sister concern, an IP Consulting Firm IIPRD announce that they are opening up a second branch Office in Bangalore w.e.f 29th July 2013, in wake of the rising client requirements and towards their goal of expanding their operations across India. K&K is a leading full … Continue reading Khurana & Khurana opens another Branch Office in Bangalore
Read more »Monsanto’s Patent on Method of Producing Transgenic Plants refused by IPAB
Monsanto’s Indian patent application 2407/DEL/NP/2006 on transgenic plants with heat/salt/draught tolerant plants is rejected by IPAB. The subject patent application is directed to a method of producing a draught/stress/heat/salt/drug tolerant transgenic plants by inserting a recombinant DNA molecule that expresses a cold shock protein CspA or CspB. The subject patent application was rejected by the … Continue reading Monsanto’s Patent on Method of Producing Transgenic Plants refused by IPAB
Read more »IPO displays Month & year of RFE that are being examined
Indian Patent Office (IPO) makes available a dynamic grid here also shown below: IPO will make the month and year for the Request for Examination (RFE) filed that are currently being examined and the First Examination Report (FER) being issued, for each of the Groups, as displayed hereinabove. IPO also states that if FER is … Continue reading IPO displays Month & year of RFE that are being examined
Read more »Draft Patents (Amendment) Rules 2013
Indian Patent Office (IPO) has recently published Draft Patents (Amendment) Rules 2013 here and has invited comments (objections or suggestions) from public within 45 days from the publication of the notification (12th June 2013). The main changes proposed are the following: 1. There is a 100% hike in official fees for almost all the proceedings … Continue reading Draft Patents (Amendment) Rules 2013
Read more »